Schizophrenia Trial, Recruiting NCT05982158 Sponsor: Swinburne University of Technology Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05982158
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a schizophrenia-related condition, or a mood disorder with psychotic symptoms, confirmed through a structured diagnostic interview
  • People who are currently hearing voices (auditory verbal hallucinations), at a level measured as moderately severe or above on a standard clinical scale
  • People who have been hearing voices for at least one year
  • People whose voices involve significant negative content and/or are causing distress, as measured by a standard rating scale
  • People who are currently taking antipsychotic medication, or who have previously tried at least two different antipsychotic medications that were stopped due to not working well enough or causing side effects
  • People who have access to the internet and a device (such as a computer, tablet, or phone) that can run video call software
  • People who speak English well enough to take part meaningfully in the trial
  • People aged 18 or older
  • People who are able to give informed consent to participate

Who may not be able to join:

  • People whose voices are thought to be caused primarily by a substance use disorder or a physical/neurological condition
  • People with an estimated IQ below 70, as measured by a specific cognitive test
  • People who have recently changed their antipsychotic medication in the past month, or who have a medication change planned at the time of joining the trial
  • People who are currently receiving, or have received in the past 3 months, individual psychological therapy for hearing voices, or who have had electroconvulsive therapy (ECT) or other brain stimulation treatments in that time
  • People whose voices speak in a language that the trial therapists do not speak

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neil Thomas, Swinburne University of Technology

Phone: +61 3 92148742

Australian sites

Swinburne University of Technology, Hawthorn, Victoria
61392144365

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Swinburne University of Technology
Registry
ClinicalTrials.gov
Start date
8 August 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Auditory verbal hallucination severity, measured by total score on the Psychotic Symptom Rating Scale - Auditory Hallucinations Scale (PSYRATS-AHS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov